New study holds promise for patients with LCA
Links shared publicly online about this topic.
- 1,138total visits
New study holds promise for patients with LCA
View full resource at news-medical.net
Tags: Genetic, Vision, Disease and Condition, Protein, Hospital, Children's Health, Childbirth, Hospitals
Most Recently Shared on May 27, 2010 at 9:21 am By:
Genetics News: New study holds promise for patients with LCA: A new study led by Dr. Robert Koenekoop at the Mon... http://buzzup.com/ygrt
Study of Bristol-Myers, AstraZeneca Diabetes Drug - Drugs.com MedNews
drugs.com — “From Associated Press (June 26, 2011) Two pharmaceutical companies said Sunday that a potential new drug for Type 2 diabetes patients holds promise after a late” View full resource at drugs.com
Most Recently Shared on June 27, 2011 at 1:16 pm By:
Drugs and Devices OW OW Health
Study of Bristol-Myers, AstraZeneca Diabetes Drug: From Associated Press (June 26, 2011) NEW YORK -- Two ... http://bit.ly/ilJEi1 #drug
Intravenous diclofenac holds promise against severe pain following oral surgery
news-medical.net — “An essential aspect of oral surgery is controlling the patient's pain following a procedure. The goal is to relieve pain and promote a rapid recovery, without opioid side effects. An initial study shows that Dyloject, a new intravenous form of the drug diclofenac, has promise for achieving these goals.” View full resource at news-medical.net
Most Recently Shared on June 27, 2011 at 5:43 am By:
Intravenous diclofenac holds promise against severe pain following oral surgery: An essential aspect of oral sur... http://bit.ly/ixvDYb
ALS Study Falls Short, But Use of Social Media Holds Promise - WSJ.com
online.wsj.com — “A new clinical trial found that lithium doesn't slow the progression of Lou Gehrig's disease, but the findings also show that its pioneering use of a social network to enroll patients and report and collect data may deliver dividends for other future studies.” View full resource at online.wsj.com
Most Recently Shared on April 25, 2011 at 11:15 am By:
Kent Bottles, MD Doctor, Pathologist, and Physician
http://ow.ly/4Gd9O ALS study of 596 patients on PatientsLikeMe shows promise of social media as research tool
ALS Study Falls Short, But Use of Social Media Holds Promise - WSJ.com
online.wsj.com — “A new clinical trial found that lithium doesn't slow the progression of Lou Gehrig's disease, but the findings also show that its pioneering use of a social network to enroll patients and report and collect data may deliver dividends for other future studies.” View full resource at online.wsj.com
Most Recently Shared on April 24, 2011 at 8:38 pm By:
Dean Giustini Health Professional
@patientslikeme Lithium study shows social media's value as accrual tool in clinical trials http://on.wsj.com/e5kQH8
ALS Study Falls Short, But Use of Social Media Holds Promise - WSJ.com
online.wsj.com — “A new clinical trial found that lithium doesn't slow the progression of Lou Gehrig's disease, but the findings also show that its pioneering use of a social network to enroll patients and report and collect data may deliver dividends for other future studies.” View full resource at online.wsj.com
Most Recently Shared on April 24, 2011 at 7:08 pm By:
George Huba, Ph.D. Doctor, Psychologist, and PhD
Experimental design pretty odd/ALS Study Falls Short, But Use of Social Media Holds Promise http://on.wsj.com/gN82if (via @news360app)
ALS Study Falls Short, But Use of Social Media Holds Promise - WSJ.com
online.wsj.com — “A new clinical trial found that lithium doesn't slow the devastating progression of Lou Gehrig's disease, but the findings released Sunday also show that its pioneering use of a social network to enroll patients and report and collect data may deliver dividends for other future studies.” View full resource at online.wsj.com
Most Recently Shared on April 24, 2011 at 6:36 pm By:
ALS Study Falls Short, But Use of Social Media Holds Promise http://on.wsj.com/e5jQwu
New drug treatments hold promise for Crohn's disease and hepatitis C patients
sciencedaily.com — “Research being presented at Digestive Disease Week shows that using telaprevir in the treatment regimen for hepatitis C virus is highly effective, particularly in difficult-to-treat cases. Further studies show that aspirin may be a factor in the development of inflammatory bowel disease.” View full resource at sciencedaily.com
Most Recently Shared on May 4, 2010 at 7:13 pm By:
New drug treatments hold promise for Crohn's disease and hepatitis C patients: Research being presented at Digesti... http://bit.ly/9DNXE6
Early Research Holds Promise For New Therapies And Better Prediction Of Patient Outcomes In Multiple Sclerosis
medicalnewstoday.com — “A Mayo Clinic study has found that two genes in mice were associated with good central nervous system repair in multiple sclerosis (MS). These findings give researchers new hope for developing mor” View full resource at medicalnewstoday.com
Most Recently Shared on September 14, 2009 at 10:11 am By:
Early Research Holds Promise For New Therapies And Better Prediction Of Patient Outcomes In Multiple Sclerosis: .. http://bit.ly/OdcaT
Advertisement
